104 related articles for article (PubMed ID: 881345)
1. Effect of ascorbate ions in DTPA treatment after contamination by mixed plutonium dioxide-sodium burning products.
Métvier H; Masse R; Nolibé D; Nénot JC; Lafuma J
Health Phys; 1977 May; 32(5):450-2. PubMed ID: 881345
[No Abstract] [Full Text] [Related]
2. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
[TBL] [Abstract][Full Text] [Related]
3. Influence of DTPA therapy on long-term effects of retained monomeric plutonium: comparison with polymeric plutonium.
Osenthal MW; Lindenbaum A
Radiat Res; 1967 Jul; 31(3):506-21. PubMed ID: 6027890
[No Abstract] [Full Text] [Related]
4. [Value of standard Licam (C) in plutonium radiocontamination].
Gerasimo P; Duserre C; Ducousso R; Metivier H
Ann Pharm Fr; 1987; 45(3):189-94. PubMed ID: 3434970
[No Abstract] [Full Text] [Related]
5. In vivo and in vitro chelation of plutonium by alpha-lipoic acid and DTPA. BNWL-714.
Dilley JV
BNWL Rep; 1968 May; ():6.12-6+. PubMed ID: 4898101
[No Abstract] [Full Text] [Related]
6. Combined effect of DTPA and citrate on an intramuscular 239Pu deposit in rats.
Volf V
Health Phys; 1974 Jul; 27(1):152-3. PubMed ID: 4430623
[No Abstract] [Full Text] [Related]
7. [Late sequelae of the inhalational uptake of 239Pu under the influence of Ca- or ZnDTPA therapy].
Levdik TI; Liubchanskii ER; Nifatov AP
Med Radiol (Mosk); 1979 Nov; 24(11):66-71. PubMed ID: 502784
[No Abstract] [Full Text] [Related]
8. Efficiency of low level DTPA therapy in removing plutonium from mice.
Smith H; Chapman IV; Marlow CG
Nature; 1969 May; 222(5194):676. PubMed ID: 5768280
[No Abstract] [Full Text] [Related]
9. Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I.
Guilmette RA; Moretti ES; Lindenbaum A
Radiat Res; 1979 Jun; 78(3):415-28. PubMed ID: 221958
[No Abstract] [Full Text] [Related]
10. Plutonium-contaminated wound studies. BNWL-714.
McClanahan BJ
BNWL Rep; 1968 May; ():6.3-6+. PubMed ID: 5307100
[No Abstract] [Full Text] [Related]
11. Experimental studies of the use of DTPA and other agents to limit the systemic burden of plutonium after wound contamination.
Harrison JD; David AJ
Radiat Res; 1979 Mar; 77(3):534-46. PubMed ID: 441257
[No Abstract] [Full Text] [Related]
12. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA.
Sérandour AL; Grémy O; Fréchou M; Renault D; Poncy JL; Fritsch P
Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819
[TBL] [Abstract][Full Text] [Related]
13. Removal of internally deposited transuranium elements by Zn-DTPA.
Seidel A; Volf V
Health Phys; 1972 Jun; 22(6):779-83. PubMed ID: 5084010
[No Abstract] [Full Text] [Related]
14. [Research in the complexon series. I. Detoxicant capacity of Ca-DTPA in experimental chronic plutonium poisoning in rats. II. Influence of the repeated intravenous administration of Ca-DTPA on the elimination of trace elements in rats. 3. Preliminary results of the study, in rats, of the modalities of calcium elimination after Ca45-DTPA injection].
Truhaut R; Boudène C; Lutz M
Ann Biol Clin (Paris); 1966; 24(3):419-39. PubMed ID: 5932716
[No Abstract] [Full Text] [Related]
15. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
Taylor DM; Hodgson SA; Stradling N
Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
[TBL] [Abstract][Full Text] [Related]
16. The use of Ca-DTPA as a treatment for plutonium inhaled in mixed oxide aerosols of plutonium and sodium.
Stather JW; Rodwell P
Health Phys; 1980 Nov; 39(5):801-5. PubMed ID: 7204032
[No Abstract] [Full Text] [Related]
17. Removal of plutonium from beagles using Ca-DTPA and Zn-DTPA: effects on initial DTPA injection.
Taylor GN; Lloyd RD; Boseman JJ; Atherton DR; Mays CW
Health Phys; 1978 Aug; 35(2):201-10. PubMed ID: 701016
[No Abstract] [Full Text] [Related]
18. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
[TBL] [Abstract][Full Text] [Related]
19. Treatment of promethium deposition in the rat. BNWL-714.
Smith VH
BNWL Rep; 1968 May; ():6.7-6+. PubMed ID: 5307101
[No Abstract] [Full Text] [Related]
20. Effectiveness of DTPA therapy when administered intragastrically or intraperitoneally to remove Pu from adult or neonatal rats.
Sullivan MF; Ruemmler PS
Health Phys; 1986 Nov; 51(5):641-6. PubMed ID: 3771225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
